Universität zu Köln

Journal Article

Johnson, Melissa Lynne, Doroshow, Deborah Blythe, Seiwert, Tanguy Y., Gibson, Michael K., Velcheti, Vamsidhar, Lisberg, Aaron Elliott, Patel, Shetal Arvind, Scheffler, Matthias, Lafleur, Francois, Dugan, Margaret Han and Sharma, Sunil (2021). Phase 1 and phase 2a, first-in-human (FIH) study, of DRP-104, a broad glutamine antagonist, in adult patients with advanced solid tumors. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755